Le Lézard
Classified in: Science and technology, Business
Subject: TNM

Thoma Bravo Announces Closing of EQS Acquisition


MUNICH and LONDON, Feb. 2, 2024 /PRNewswire/ -- Thoma Bravo, L.P. announces the closing of its successful public takeover offer (the "Offer") by Pineapple German Bidco GmbH ("Bidco"), an entity controlled by funds managed and/or advised by Thoma Bravo, L.P. (collectively, "Thoma Bravo"), to the shareholders of EQS Group AG ("EQS").

Following the closing of the Offer, Thoma Bravo holds a total stake of approx. 98% of the share capital of EQS, which includes all tendered shares, shares acquired on the market, shares subject to the partial re-investment of Achim Weick, CEO and founder of EQS, as well as the shares Thoma Bravo has subscribed for in a 10% capital increase of EQS. EQS and Thoma Bravo have agreed that the management board will arrange for the termination of the inclusion of the EQS shares in the trading on the open market (Freiverkehr) immediately after closing. A separate delisting offer will not be required. The delisting is expected to become effective in Q2 2024.

About Thoma Bravo

Thoma Bravo is one of the largest software investors in the world, with approximately US$134 billion in assets under management as of 30 September 2023. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo's deep sector knowledge and strategic and operational expertise, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20 years, the firm has acquired or invested in more than 455 companies representing over US$255 billion in enterprise value (including control and non-control investments). The firm has offices in Chicago, London, Miami, New York and San Francisco. For more information, visit Thoma Bravo's website at thomabravo.com.

Legal Disclaimer

This publication is neither an offer to purchase nor a solicitation of an offer to sell shares in EQS or any other securities.

This publication may contain statements about Thoma Bravo, and/or EQS and/or either of its affiliates that are or may be "forward-looking statements", i.e., statements about processes that take place in the future, not in the past. Forward-looking statements include, without limitation, statements that typically contain words such as "seek", "estimate", "intend", "plan", "believe", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. By their nature, forward-looking statements are based on current expectations, assumptions, estimates and projections and involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and many of which are outside the control of Thoma Bravo, EQS and/or any of its affiliates. Thoma Bravo and EQS caution you that forward-looking statements are not guarantees of the occurrence of such future events or of future performance. Any forward-looking statement speaks only as at the date of this announcement. Except as required by applicable law, Thoma Bravo does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Thoma Bravo


These press releases may also interest you

at 07:45
Oracle Hospitality today announced that it has signed an agreement with Choice Hotels International, one of the largest lodging franchisors in the world, to extend its AI-powered merchandising solution Oracle...

at 07:45
The following issues have been halted by CIRO Company: Fraser Mackenzie Accelerator Corp. TSX-Venture Symbol: FMAC.P All Issues: Yes Reason: Pending News Halt Time (ET): 7:37 AM CIRO can make a decision to impose a temporary suspension (halt) of...

at 07:43
The Winners Circle, an innovative rewards programme and loyalty platform for horse racing fans, is delighted to announce its partnership with Saffie Osborne, an esteemed British flat racing jockey with more than 200 race wins....

at 07:40
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of...

at 07:35
Smith Douglas Homes Corp. ("Smith Douglas" or the "Company") today announced first quarter results for the three months ended March 31, 2024. Q1 2024 Results as compared to Q1 2023: Net new orders increased 15% to 765 Home closings increased...

at 07:35
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate...



News published on and distributed by: